Last Price$371.8(1.5%)
Market Cap$22.2B
LTM Rule of 40 (EBIT margin)
28.4%
5Y avg
32.5%
Medical - Diagnostics & Research industry
median
(21.0%)
Stock quality & Intrinsic value
6/10
(0.4%) overvalued
Waters Corporation Rule of 40 (EBIT margin)
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rule of 40 (EBIT margin) | 0.0% | 29.3% | 33.6% | 38.7% | 31.7% | 21.5% | 37.0% | 41.2% | 27.3% | 30.5% | 30.5% | 30.4% | 34.9% | 35.2% | 35.4% | 28.9% | 25.6% | 47.3% | 36.1% | 27.1% |
Overvalued or undervalued?
Check the intrinsic value for WAT
and see if it's the right time to invest.
Waters Corporation (WAT) Rule of 40 (EBIT margin) comparison analysis
General
LTM Rule of 40 (EBIT margin)
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Waters CorporationWAT
28.4%
(0.5%)
(7.9%)
21.7%
Median Peer Set
20.5%
(1.5%)
(2.0%)
11.6%
Natera, Inc.NTRA
39.1%
32.0%
(32.1%)
(40.2%)
IDEXX Laboratories, Inc.IDXX
35.5%
8.7%
25.2%
23.1%
Mettler-Toledo International Inc.MTD
33.2%
2.2%
12.7%
22.3%
Illumina, Inc.ILMN
27.7%
(2.9%)
4.6%
(28.0%)
Quest Diagnostics IncorporatedDGX
20.7%
(6.4%)
(6.5%)
9.2%
Danaher CorporationDHR
20.3%
(0.1%)
(17.9%)
16.3%
Agilent Technologies, Inc.A
19.7%
(4.7%)
5.0%
19.8%
Thermo Fisher Scientific Inc.TMO
17.2%
(4.6%)
(12.4%)
14.0%
IQVIA Holdings Inc.IQV
17.1%
2.8%
2.4%
8.9%
Laboratory Corporation of America HoldingsLH
9.3%
(18.3%)
(65.8%)
3.4%
WAT key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,104.5 0.0% | 1,158.2 4.9% | 1,280.2 10.5% | 1,473.0 15.1% | 1,575.1 6.9% | 1,498.7 (4.9%) | 1,643.4 9.7% | 1,851.2 12.6% | 1,843.6 (0.4%) | 1,904.2 3.3% | 1,989.3 4.5% | 2,042.3 2.7% | 2,167.4 6.1% | 2,309.1 6.5% | 2,419.9 4.8% | 2,406.6 (0.6%) | 2,365.4 (1.7%) | 2,785.9 17.8% | 2,972.0 6.7% | 2,956.4 (0.5%) |
| Cost of Goods Sold (COGS) | 454.8 | 478.4 | 536.2 | 631.1 | 661.3 | 594.9 | 653.3 | 730.5 | 737.6 | 783.5 | 824.9 | 842.7 | 891.5 | 947.1 | 992.6 | 1,010.7 | 1,006.7 | 1,156.5 | 1,248.2 | 1,195.2 |
% margin | 649.7 58.8% | 679.9 58.7% | 744.0 58.1% | 841.9 57.2% | 913.9 58.0% | 903.8 60.3% | 990.1 60.2% | 1,120.7 60.5% | 1,106.0 60.0% | 1,120.8 58.9% | 1,164.4 58.5% | 1,199.7 58.7% | 1,276.0 58.9% | 1,362.0 59.0% | 1,427.4 59.0% | 1,395.9 58.0% | 1,358.7 57.4% | 1,629.3 58.5% | 1,723.8 58.0% | 1,761.2 59.6% |
| Operating Expenses | 364.9 | 396.7 | 440.4 | 493.0 | 524.1 | 509.2 | 540.1 | 592.1 | 587.1 | 603.4 | 631.1 | 624.4 | 648.1 | 684.0 | 688.0 | 687.4 | 705.1 | 802.5 | 840.6 | 943.5 |
| Research & Development Expenses (R&D) | 65.2 | 66.9 | 77.3 | 80.6 | 81.6 | 77.2 | 84.3 | 92.3 | 96.0 | 100.5 | 107.7 | 118.5 | 125.2 | 132.6 | 143.4 | 143.0 | 140.8 | 168.4 | 176.2 | 174.9 |
| Selling, General & Administrative Expenses (SG&A) | 300.2 | 321.7 | 357.7 | 403.7 | 426.7 | 421.4 | 445.5 | 490.0 | 477.3 | 493.0 | 512.7 | 495.7 | 513.0 | 544.7 | 536.9 | 534.8 | 553.7 | 627.0 | 658.0 | 736.0 |
% margin | 284.9 25.8% | 283.2 24.4% | 295.2 23.1% | 348.9 23.7% | 389.8 24.7% | 394.6 26.3% | 449.9 27.4% | 528.6 28.6% | 511.5 27.7% | 517.3 27.2% | 517.9 26.0% | 567.5 27.8% | 624.3 28.8% | 661.9 28.7% | 739.8 30.6% | 708.5 29.4% | 645.5 27.3% | 821.7 29.5% | 873.4 29.4% | 817.7 27.7% |
| Interest Income | 0.0 | 19.3 | 0.0 | 0.0 | 0.0 | 3.0 | 1.9 | 2.6 | 4.2 | 4.4 | 7.0 | 10.7 | 20.7 | 36.1 | 38.8 | 22.1 | 16.3 | 12.2 | 11.0 | 16.6 |
| Interest Expense | 0.0 | 8.6 | 32.2 | 25.7 | 17.6 | 8.0 | 12.1 | 19.3 | 23.9 | 25.7 | 27.2 | 25.5 | 24.2 | 20.8 | 9.8 | 26.6 | 32.8 | 32.7 | 37.8 | 98.9 |
| Pre-tax Income | 285.7 | 274.6 | 263.0 | 323.2 | 372.2 | 386.7 | 437.9 | 509.3 | 487.6 | 490.1 | 490.7 | 541.9 | 600.1 | 641.1 | 682.1 | 678.2 | 610.9 | 806.2 | 837.8 | 736.2 |
% effective tax rate | 61.6 21.6% | 72.6 26.4% | 40.8 15.5% | 55.1 17.1% | 49.7 13.4% | 63.3 16.4% | 56.1 12.8% | 76.3 15.0% | 26.2 5.4% | 40.1 8.2% | 59.1 12.0% | 72.9 13.4% | 78.6 13.1% | 620.8 96.8% | 88.4 13.0% | 86.0 12.7% | 89.3 14.6% | 113.4 14.1% | 130.1 15.5% | 94.0 12.8% |
% margin | 224.1 20.3% | 202.0 17.4% | 222.2 17.4% | 268.1 18.2% | 322.5 20.5% | 323.3 21.6% | 381.8 23.2% | 433.0 23.4% | 461.4 25.0% | 450.0 23.6% | 431.6 21.7% | 469.1 23.0% | 521.5 24.1% | 20.3 0.9% | 593.8 24.5% | 592.2 24.6% | 521.6 22.1% | 692.8 24.9% | 707.8 23.8% | 642.2 21.7% |
| EPS | 1.87 | 1.77 | 2.16 | 2.67 | 3.25 | 3.37 | 4.13 | 4.77 | 5.25 | 5.27 | 5.12 | 5.70 | 6.46 | 0.25 | 7.71 | 8.76 | 8.40 | 11.25 | 11.80 | 10.87 |
| Diluted EPS | 1.82 | 1.74 | 2.13 | 2.62 | 3.21 | 3.34 | 4.06 | 4.69 | 5.19 | 5.20 | 5.07 | 5.65 | 6.41 | 0.25 | 7.65 | 8.69 | 8.36 | 11.17 | 11.73 | 10.84 |
% margin | 337.7 30.6% | 326.8 28.2% | 360.8 28.2% | 402.2 27.3% | 476.0 30.2% | 454.9 30.4% | 514.3 31.3% | 597.6 32.3% | 584.5 31.7% | 597.0 31.4% | 638.3 32.1% | 668.2 32.7% | 725.0 33.5% | 784.0 34.0% | 799.6 33.0% | 822.1 34.2% | 778.0 32.9% | 958.4 34.4% | 1,014.1 34.1% | 1,001.0 33.9% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Waters Corporation's Rule of 40 (EBIT margin)?
As of today, Microsoft Corp's last 12-month Rule of 40 (EBIT margin) is 28.4%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Rule of 40 (EBIT margin) for Waters Corporation have been 34.7% over the past three years, and 34.1% over the past five years.
2) Is Waters Corporation's Rule of 40 (EBIT margin) Good?
As of today, Waters Corporation's Rule of 40 (EBIT margin) is 28.4%, which is higher than industry median of (21.0%). It indicates that Waters Corporation's Rule of 40 (EBIT margin) is Good.